Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zahra Gharailoo

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Allergy|April 7, 2025
Vaccine-Induced Anti-IgE Antibodies Neutralize Free IgE but Fail to Bind and Activate Mast Cell-Displayed IgEZahra Gharailoo, Monique Vogel, Paul Engeroff, et al.
Allergy|March 12, 2026
A Case for Anti-IgE VaccinationPaul Engeroff, Zahra Gharailoo, Monique Vogel, et al.
Maedica|July 12, 2017
Antimicrobial Resistant Pattern and Capsular Typing of Streptococcus Pneumoniae Isolated from Children in Sistan -BaluchestanZahra Gharailoo, Seyed Fazlollah Mousavi, Niloofar Halvani, et al.
Frontiers in Immunology|December 22, 2022
IgE glycans promote anti-IgE IgG autoantibodies that facilitate IgE serum clearance <i>via</i> Fc ReceptorsKevin Plattner, Zahra Gharailoo, Simon Zinkhan, et al.
Allergy|March 6, 2024
Generation of a virus-like particles based vaccine against IgEZahra Gharailoo, Kevin Plattner, Gilles Augusto, et al.
Vaccines|November 27, 2021
A Novel Double Mosaic Virus-like Particle-Based Vaccine against SARS-CoV-2 Incorporates Both Receptor Binding Motif (RBM) and Fusion DomainXinyue Chang, Andris Zeltins, Mona O Mohsen, et al.
NPJ Vaccines|August 25, 2021
Neutralization of MERS coronavirus through a scalable nanoparticle vaccineMona O Mohsen, Dominik Rothen, Ina Balke, et al.
Allergy|September 8, 2021
A scalable and highly immunogenic virus-like particle-based vaccine against SARS-CoV-2Mona O Mohsen, Ina Balke, Simon Zinkhan, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Allergy|April 7, 2025
Vaccine-Induced Anti-IgE Antibodies Neutralize Free IgE but Fail to Bind and Activate Mast Cell-Displayed IgEZahra Gharailoo, Monique Vogel, Paul Engeroff, et al.
Allergy|March 12, 2026
A Case for Anti-IgE VaccinationPaul Engeroff, Zahra Gharailoo, Monique Vogel, et al.
Maedica|July 12, 2017
Antimicrobial Resistant Pattern and Capsular Typing of Streptococcus Pneumoniae Isolated from Children in Sistan -BaluchestanZahra Gharailoo, Seyed Fazlollah Mousavi, Niloofar Halvani, et al.
Frontiers in Immunology|December 22, 2022
IgE glycans promote anti-IgE IgG autoantibodies that facilitate IgE serum clearance <i>via</i> Fc ReceptorsKevin Plattner, Zahra Gharailoo, Simon Zinkhan, et al.
Allergy|March 6, 2024
Generation of a virus-like particles based vaccine against IgEZahra Gharailoo, Kevin Plattner, Gilles Augusto, et al.
Vaccines|November 27, 2021
A Novel Double Mosaic Virus-like Particle-Based Vaccine against SARS-CoV-2 Incorporates Both Receptor Binding Motif (RBM) and Fusion DomainXinyue Chang, Andris Zeltins, Mona O Mohsen, et al.
NPJ Vaccines|August 25, 2021
Neutralization of MERS coronavirus through a scalable nanoparticle vaccineMona O Mohsen, Dominik Rothen, Ina Balke, et al.
Allergy|September 8, 2021
A scalable and highly immunogenic virus-like particle-based vaccine against SARS-CoV-2Mona O Mohsen, Ina Balke, Simon Zinkhan, et al.
Pageof 1